Doxepin Treatment of Depressed Patients With Chronic Obstructive Pulmonary Disease
The DOI matches its OpenAlex record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
During each of two six-week treatment periods, 12 depressed outpatients with chronic obstructive pulmonary disease received increasing doses of doxepin hydrochloride or a placebo as tolerated. The mean maximal doses of doxepin hydrochloride and placebo were 105 and 128 mg, respectively. Three of the 12 patients dropped out because of doxepin's side effects. The depression and anxiety scores at the end of the treatment periods were virtually identical and not significantly different from baseline scores. Changes in the 12-minute walking distance were more closely correlated with changes in the depression and anxiety scores than with changes in the forced expiratory volume in 1 s or forced vital capacity. Thus, doxepin is ineffective in treating depressed patients with chronic obstructive pulmonary disease; improvements in the 12-minute walking distance were closely correlated with improvements in the depression or anxiety scores.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Life quality of patients with chronic obstructive pulmonary disease
McSweeny, A. J. (1982) · Archives of Internal Medicine · doi:10.1001/archinte.1982.00340160057014 · Cited by 490
Prevalence of Depression and Anxiety in Patients with COPD
Light, R. W., Merrill, E. J., Despars, J. A., Gordon, G. H., & Mutalipassi, L. R. (1985) · Chest · doi:10.1378/chest.87.1.35 · Cited by 262
Self-citation
Cited by
Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review
Mikkelsen, R. L., Middelboe, T., Pisinger, C., & Stage, K. B. (2004) · Nordic Journal of Psychiatry · doi:10.1080/08039480310000824 · Cited by 345
“There are some suggestions that imipramine and amitriptyline relieve symptoms of depression as well as improve pulmonary function in this patient group (27), but a placebo-controlled study (28) turned out negatively.”
BackgroundAnxiety and depression-Important psychological comorbidities of COPD.
Pumar, M., Gray, C. R., Walsh, J., Yang, I. A., Rolls, T., & Ward, D. L. (2014) · PubMed · doi:10.3978/j.issn.2072-1439.2014.09.28 · Cited by 272
Anxiety and depression in end-stage COPD
Hill, K., Geist, R., Goldstein, R. S., & Lacasse, Y. (2008) · European Respiratory Journal · doi:10.1183/09031936.00125707 · Cited by 269
Depression in patients with cancer
Mermelstein, H. T., & Lesko, L. (1992) · Psycho-Oncology · doi:10.1002/pon.2960010404 · Cited by 266
Marciniuk, D. D., Goodridge, D., Hernandez, P., Rocker, G., Balter, M., Bailey, P., Ford, G., Bourbeau, J., O’Donnell, D. E., Maltais, F., et al. (2011) · Canadian Respiratory Journal · doi:10.1155/2011/745047 · Cited by 264
Metadata
- Authors
- Light, R. W.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association
- Published
- 1986-07-01
- Volume
- 146
- Issue
- 7
- Pages
- 1377-1377
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W1974802510
- Cited by
- 74
- References
- 2
- FWCI
- 1.04
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.